Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))

Marie R. Webster; Mitchell E. Fane; Gretchen M. Alicea; Subhasree Basu; Andrew V. Kossenkov; Gloria E. Marino; Stephen M. Douglass; Amanpreet Kaur; Brett L. Ecker; Keerthana Gnanapradeepan; Abibatou Ndoye; Curtis Kugel; Alexander Valiga; Jessica Palmer; Qin Liu; Xiaowei Xu; Jessicamarie Morris; Xiangfan Yin; Hong Wu; Wei Xu; Cathy Zheng; Giorgos C. Karakousis; Ravi K. Amaravadi; Tara C. Mitchell; Filipe V. Almeida; Min Xiao; Vito W. Rebecca; Ying Jie Wang; Lynn M. Schuchter; Meenhard Herlyn; Maureen E. Murphy; Ashani T. Weeraratna

doi:10.1016/j.molcel.2020.01.005

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))

Marie R. Webster, Mitchell E. Fane, Gretchen M. Alicea, Subhasree Basu, Andrew V. Kossenkov, Gloria E. Marino, Stephen M. Douglass, Amanpreet Kaur, Brett L. Ecker, Keerthana Gnanapradeepan, Abibatou Ndoye, Curtis Kugel, Alexander Valiga, Jessica Palmer, Qin Liu, Xiaowei Xu, Jessicamarie Morris, Xiangfan Yin, Hong Wu, Wei XuCathy Zheng, Giorgos C. Karakousis, Ravi K. Amaravadi, Tara C. Mitchell, Filipe V. Almeida, Min Xiao, Vito W. Rebecca, Ying Jie Wang, Lynn M. Schuchter, Meenhard Herlyn, Maureen E. Murphy, Ashani T. Weeraratna

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Abstract

(Molecular Cell 77, 633–644.e1–e5; February 6, 2020) Due to a miscommunication, the name Tara Miller was inadvertently added to the author list. This has since been amended, and the name now appears correctly online and in print as part of an affiliation, the Tara Miller Melanoma Center at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. The authors regret this error.

Original language	English
Pages (from-to)	681
Number of pages	1
Journal	Molecular Cell
Volume	77
Issue number	3
DOIs	https://doi.org/10.1016/j.molcel.2020.01.005
State	Published - Feb 6 2020

Access to Document

10.1016/j.molcel.2020.01.005

Fingerprint

Dive into the research topics of 'Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))'. Together they form a unique fingerprint.

Cite this

Webster, M. R., Fane, M. E., Alicea, G. M., Basu, S., Kossenkov, A. V., Marino, G. E., Douglass, S. M., Kaur, A., Ecker, B. L., Gnanapradeepan, K., Ndoye, A., Kugel, C., Valiga, A., Palmer, J., Liu, Q., Xu, X., Morris, J., Yin, X., Wu, H., ... Weeraratna, A. T. (2020). Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009)). Molecular Cell, 77(3), 681. https://doi.org/10.1016/j.molcel.2020.01.005

Webster, Marie R. ; Fane, Mitchell E. ; Alicea, Gretchen M. et al. / Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma : Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009)). In: Molecular Cell. 2020 ; Vol. 77, No. 3. pp. 681.

@article{c724552884ae4cc2a976e33527e01547,

title = "Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))",

abstract = "(Molecular Cell 77, 633–644.e1–e5; February 6, 2020) Due to a miscommunication, the name Tara Miller was inadvertently added to the author list. This has since been amended, and the name now appears correctly online and in print as part of an affiliation, the Tara Miller Melanoma Center at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. The authors regret this error.",

author = "Webster, {Marie R.} and Fane, {Mitchell E.} and Alicea, {Gretchen M.} and Subhasree Basu and Kossenkov, {Andrew V.} and Marino, {Gloria E.} and Douglass, {Stephen M.} and Amanpreet Kaur and Ecker, {Brett L.} and Keerthana Gnanapradeepan and Abibatou Ndoye and Curtis Kugel and Alexander Valiga and Jessica Palmer and Qin Liu and Xiaowei Xu and Jessicamarie Morris and Xiangfan Yin and Hong Wu and Wei Xu and Cathy Zheng and Karakousis, {Giorgos C.} and Amaravadi, {Ravi K.} and Mitchell, {Tara C.} and Almeida, {Filipe V.} and Min Xiao and Rebecca, {Vito W.} and Wang, {Ying Jie} and Schuchter, {Lynn M.} and Meenhard Herlyn and Murphy, {Maureen E.} and Weeraratna, {Ashani T.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = feb,

day = "6",

doi = "10.1016/j.molcel.2020.01.005",

language = "English",

volume = "77",

pages = "681",

journal = "Molecular Cell",

issn = "1097-2765",

publisher = "Cell Press",

number = "3",

}

Webster, MR, Fane, ME, Alicea, GM, Basu, S, Kossenkov, AV, Marino, GE, Douglass, SM, Kaur, A, Ecker, BL, Gnanapradeepan, K, Ndoye, A, Kugel, C, Valiga, A, Palmer, J, Liu, Q, Xu, X, Morris, J, Yin, X, Wu, H, Xu, W, Zheng, C, Karakousis, GC, Amaravadi, RK, Mitchell, TC, Almeida, FV, Xiao, M, Rebecca, VW, Wang, YJ, Schuchter, LM, Herlyn, M, Murphy, ME & Weeraratna, AT 2020, 'Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))', Molecular Cell, vol. 77, no. 3, pp. 681. https://doi.org/10.1016/j.molcel.2020.01.005

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009)). / Webster, Marie R.; Fane, Mitchell E.; Alicea, Gretchen M. et al.
In: Molecular Cell, Vol. 77, No. 3, 06.02.2020, p. 681.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma

T2 - Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))

AU - Webster, Marie R.

AU - Fane, Mitchell E.

AU - Alicea, Gretchen M.

AU - Basu, Subhasree

AU - Kossenkov, Andrew V.

AU - Marino, Gloria E.

AU - Douglass, Stephen M.

AU - Kaur, Amanpreet

AU - Ecker, Brett L.

AU - Gnanapradeepan, Keerthana

AU - Ndoye, Abibatou

AU - Kugel, Curtis

AU - Valiga, Alexander

AU - Palmer, Jessica

AU - Liu, Qin

AU - Xu, Xiaowei

AU - Morris, Jessicamarie

AU - Yin, Xiangfan

AU - Wu, Hong

AU - Xu, Wei

AU - Zheng, Cathy

AU - Karakousis, Giorgos C.

AU - Amaravadi, Ravi K.

AU - Mitchell, Tara C.

AU - Almeida, Filipe V.

AU - Xiao, Min

AU - Rebecca, Vito W.

AU - Wang, Ying Jie

AU - Schuchter, Lynn M.

AU - Herlyn, Meenhard

AU - Murphy, Maureen E.

AU - Weeraratna, Ashani T.

PY - 2020/2/6

Y1 - 2020/2/6

N2 - (Molecular Cell 77, 633–644.e1–e5; February 6, 2020) Due to a miscommunication, the name Tara Miller was inadvertently added to the author list. This has since been amended, and the name now appears correctly online and in print as part of an affiliation, the Tara Miller Melanoma Center at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. The authors regret this error.

AB - (Molecular Cell 77, 633–644.e1–e5; February 6, 2020) Due to a miscommunication, the name Tara Miller was inadvertently added to the author list. This has since been amended, and the name now appears correctly online and in print as part of an affiliation, the Tara Miller Melanoma Center at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=85078705495&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2020.01.005

DO - 10.1016/j.molcel.2020.01.005

M3 - Comment/debate

C2 - 32032511

SN - 1097-2765

VL - 77

SP - 681

JO - Molecular Cell

JF - Molecular Cell

IS - 3

ER -

Webster MR, Fane ME, Alicea GM, Basu S, Kossenkov AV, Marino GE et al. Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009)). Molecular Cell. 2020 Feb 6;77(3):681. doi: 10.1016/j.molcel.2020.01.005

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this